Feiyang Qi

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Characterization of Parthanatos in Breast Cancer: Implications for Prognosis and PARP Inhibitor Resistance”.

Characterization of Parthanatos in Breast Cancer: Implications for Prognosis and PARP Inhibitor Resistance

Bioengineering(2025)10.3390/bioengineering12060586

N/A

0.104DataRank · unranked

1 citations

Jun Li, Wei Du, Linxi Chen, Feiyang Qi, Ranxin Zhang +6 more

A pan-cancer analysis revealed SKP2 as an inhibitor of the tumor immune microenvironment and a promising therapeutic target for immunotherapy

Precision Clinical Medicine(2025)10.1093/pcmedi/pbaf022

N/A

0DataRank · unranked

2 citations

Yaxin Zhang, Xue Yu, Wei Du, Linxi Chen, Zhiqing Zhao +9 more

Development of a global forearm reconstruction system for post-tumor resection defects of the radius or ulna: a proof-of-concept study

Frontiers in Bioengineering and Biotechnology(2025)10.3389/fbioe.2025.1547652

N/A

0DataRank · unranked

0 citations

Jie Zang, Siyi Huang, Boyang Wang, Shun Tang, Zhiye Du +5 more